Europe Drug Delivery Systems Market to 2027- Regional Analysis and Forecasts By Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others) and Geography
Publication Month: Jun 2019
Report Code: TIPRE00005753 No. of Pages: 235 Category: Medical Device Status: Published
The Europe drug delivery systems market is expected to reach US$ 610,320.4 Mn in 2027 from US$ 343,533.9 in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027.
Factors such as rising investments by pharmaceutical companies and medical device companies in research and development and rise of chronic disease conditions in Europe is expected to foster the growth of the Europe drug delivery systems market. On the other hand, regulatory recalls for drug delivery systems by European manufacturers are likely to create a negative impact on the market growth to an extent.
Products with the innovative technology with more effective benefits is a major requirement in the treatment for various chronic diseases. The advancement and development in the treatment are increasing in the last few years. As the prevalence of chronic diseases is increasing in the European region, the demand for more products with advancements is also boosting up. Hence, over the years, researchers have been carrying out research activities which have resulted in product innovations.
For instance, in July 2018, the Roche received CE mark for its innovative Accu-Chek Solo micropump system. The system is a small tube-free insulin delivery device that offers to their users the choice to bolus directly from the pump. The system is a fully functional handheld that comprises detach and re-attach function of pump without wasting insulin. The Accu-Chek Solo micropump integrates and the Roche’s digital health solutions contributing in a combination to provide more effective and personalized diabetes management to their users. The innovations in the drug delivery systems are thus likely to be a prevalent trend in the global drug delivery systems market over the coming years.
EUROPE DRUG DELIVERY SYSTEMS– MARKET SEGMENTATION
By Route of Administration
- Oral
- Solid Oral Drugs
- Liquid Oral Drugs
- Semi-solid Oral Drugs
- Transmucosal
- Pulmonary Drug Delivery
- In-metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Nasal Drug Delivery
- Nasal Sprays
- Nasal Drops
- Nasal Gels
- Buccal Drug Delivery
- Sublingual Drug Delivery
- Rectal Transmucosal Drug delivery
- Vaginal Transmucosal Drug Delivery
- Pulmonary Drug Delivery
- Injectable
- Conventional Injection Devices
- Self-Injection Devices
- Needle Free Injectors
- Pen Injectors
- Wearable Injectors
- Topical
- Semi-solid Topical Drug Delivery Formulations
- Liquid Topical Drug Delivery Formulations
- Solid Topical Drug Delivery Formulations
- Transdermal Patches
- Transdermal Gels
- Others
- Implantable
- Active Implantable
- Passive Implantable
- Ocular
- Eye Drops & Sprays
- Gels & Ointments
- Ocular Inserts
- Drug Coated Contact Lenses
By Application
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Country
- Germany
- France
- UK
Companies Mentioned
- BD
- Novo Nordisk A/S
- 3M
- Boston Scientific Corporation
- Bausch Health Companies Inc.
- Baxter International, Inc.
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. Europe Drug Delivery Systems Market – Key Takeaways
3. Europe Drug Delivery Systems Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Drug Delivery Systems Market – By Route of Administration
3.2.2 Europe Drug Delivery Systems Market – By Application
3.2.3 Europe Drug Delivery Systems Market – By Distribution Channel
3.2.4 Europe Drug Delivery Systems Market – By Country
3.3 PEST Analysis
4. Europe Drug Delivery Systems Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Investments by Pharmaceutical and Medical Device Companies in R&D
4.1.2 Rise of Chronic Disease Conditions in Europe
4.2 Key Market Restraints
4.2.1 Recent Product Recalls for Drug Delivery Systems in Europe
4.3 Key Market Opportunities
4.3.1 Growing Prevalence of Infectious Diseases
4.4 Future Trends
4.4.1 New Drug Delivery Systems In Development
4.5 Impact Analysis
5. Drug Delivery Systems Market – Europe Analysis
5.1 Europe Drug Delivery Systems Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
6. Europe Drug Delivery Systems Market Analysis – By Route Of Administration
6.1 Overview
6.2 Europe Drug Delivery Systems Market, By Route of Administration, 2018 & 2027 (%)
6.3 Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
6.4 Oral Drug Delivery Market
6.4.1 Overview
6.4.2 Oral Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.4.3 Solid Oral Drugs Market
6.4.3.1 Overview
6.4.3.2 Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
6.4.4 Liquid Oral Drugs Market
6.4.4.1 Overview
6.4.4.2 Liquid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
6.4.5 Semi-Solid Oral Drugs Market
6.4.5.1 Overview
6.4.5.2 Semi-Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Transmucosal Drug Delivery Market
6.5.1 Overview
6.5.2 Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3 Pulmonary Drug Delivery Market
6.5.3.1 Overview
6.5.3.2 Pulmonary Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3.3 In-metered Dose Inhalers Market
6.5.3.3.1 Overview
6.5.3.3.2 In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3.4 Dry Powder Inhalers Market
6.5.3.4.1 Overview
6.5.3.4.2 Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3.5 Nebulizers Market
6.5.3.5.1 Overview
6.5.3.5.2 Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4 Nasal Drug Delivery Market
6.5.4.1 Overview
6.5.4.2 Nasal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4.3 Nasal Spray Market
6.5.4.3.1 Overview
6.5.4.3.2 Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4.4 Nasal Drops Market
6.5.4.4.1 Overview
6.5.4.4.2 Nasal Drops Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4.5 Nasal Gel Market
6.5.4.5.1 Overview
6.5.4.5.2 Nasal Gel Market Revenue and Forecast to 2027 (US$ Mn)
6.5.5 Buccal Drug Delivery Market
6.5.5.1 Overview
6.5.5.2 Buccal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.6 Sublingual Drug Delivery Market
6.5.6.1 Overview
6.5.6.2 Sublingual Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.7 Rectal Transmucosal Drug Delivery Market
6.5.7.1 Overview
6.5.7.2 Rectal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.8 Vaginal Transmucosal Drug Delivery Market
6.5.8.1 Overview
6.5.8.2 Vaginal Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Topical Drug Delivery Market
6.6.1 Overview
6.6.2 Topical Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.6.3 Semi-solid Topical Drug Delivery Formulations Market
6.6.3.1 Overview
6.6.3.2 Semi-solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
6.6.4 Liquid Topical Drug Delivery Formulations Market
6.6.4.1 Overview
6.6.4.2 Liquid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
6.6.5 Solid Topical Drug Delivery Formulations Market
6.6.5.1 Overview
6.6.5.2 Solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
6.6.6 Transdermal Patches Market
6.6.6.1 Overview
6.6.6.2 Transdermal Patches Market Revenue and Forecast to 2027 (US$ Mn)
6.6.7 Transdermal Gels Market
6.6.7.1 Overview
6.6.7.2 Transdermal Gels Market Revenue and Forecast to 2027 (US$ Mn)
6.6.8 Others Market
6.6.8.1 Overview
6.6.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
6.7 Injectable Drug Delivery Market
6.7.1 Overview
6.7.2 Injectable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.7.3 Conventional Injection Devices Market
6.7.3.1 Overview
6.7.3.2 Conventional Injection Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.7.4 Self-Injection Devices Market
6.7.4.1 Overview
6.7.4.2 SELF-INJECTION Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.7.4.3 Needle Free Injectors Market
6.7.4.3.1 Overview
6.7.4.3.2 Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)
6.7.4.4 Pen injectors Market
6.7.4.4.1 Overview
6.7.4.4.2 Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)
6.7.4.5 Wearable Injectors Market
6.7.4.5.1 Overview
6.7.4.5.2 Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)
6.8 Implantable Drug Delivery Market
6.8.1 Overview
6.8.2 Implantable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.8.3 Active Implantable Market
6.8.3.1 Overview
6.8.3.2 Active Implantable Market Revenue and Forecast to 2027 (US$ Mn)
6.8.4 Passive Implantable Market
6.8.4.1 Overview
6.8.4.2 Passive Implantable Market Revenue and Forecast to 2027 (US$ Mn)
6.9 Ocular Drug Delivery Market
6.9.1 Overview
6.9.2 Ocular Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.9.3 Eye Drops and Sprays Market
6.9.3.1 Overview
6.9.3.2 Eye Drops and Sprays Market Revenue and Forecast to 2027 (US$ Mn)
6.9.4 Gels & Ointments Market
6.9.4.1 Overview
6.9.4.2 Gels & Ointments Market Revenue and Forecast to 2027 (US$ Mn)
6.9.5 Ocular Inserts Market
6.9.5.1 Overview
6.9.5.2 Ocular Inserts Market Revenue and Forecast to 2027 (US$ Mn)
6.9.6 Drug Coated Contact Lens Market
6.9.6.1 Overview
6.9.6.2 Drug Coated Contact Lens Market Revenue and Forecast to 2027 (US$ Mn)
7. Europe Drug Delivery Systems Market Analysis – By Application
7.1 Overview
7.2 Europe Drug Delivery Systems Market, By Application, 2018 & 2027 (%)
7.3 Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
7.4 Homecare Settings Market
7.4.1 Overview
7.4.2 Europe Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Hospitals & Clinics Market
7.5.1 Overview
7.5.2 Europe Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Others Market
7.6.1 Overview
7.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Europe Drug Delivery Systems Market Analysis – By Distribution Channel
8.1 Overview
8.2 Europe Drug Delivery Systems Market, By Distribution Channel, 2018 & 2027 (%)
8.3 Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
8.4 Hospital Pharmacies Market
8.4.1 Overview
8.4.2 Europe Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Retail Pharmacies Market
8.5.1 Overview
8.5.2 Europe Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Online Pharmacies Market
8.6.1 Overview
8.6.2 Europe Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027
9.1.1 Overview
9.1.2 Europe Drug Delivery Systems Market revenue Overview, by Country (2017) (US$ Mn)
9.1.3 Europe Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.4 Europe Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
9.1.4.1 Europe Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.2 Europe oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.3 Europe Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.4 Europe Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.5 Europe Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.6 Europe Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.7 Europe Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.8 Europe Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.9 Europe Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.5 Europe Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.6 Europe Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.7 Europe Drug Delivery Systems Market Revenue and Forecasts to 2027, By Country (%)
9.1.8 Germany Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9 Germany Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Germany Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
9.1.9.1.1 Germany Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.2 Germany Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.3 Germany Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.4 Germany Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.4.1 Germany Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.5 Germany Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.6 Germany Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.7 Germany Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.8 Germany Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.2 Germany Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.9.3 Germany Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.10 France Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11 France Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11.1 France Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
9.1.11.1.1 France Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.2 France Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.3 France Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.4 France Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.5 France Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.6 France Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.7 France Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.8 France Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.9 France Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.2 France Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.11.3 France Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.12 UK Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.13 UK Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.13.1 UK Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
9.1.13.1.1 UK Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.2 UK Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.3 UK Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.4 UK Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.5 UK Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.6 UK Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.7 UK Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.8 UK Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.9 UK Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.2 UK Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.13.3 UK Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10. Drug Delivery Systems Market – Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies Done by the Companies in the Market, (%)
10.4 Organic Developments
10.4.1 Overview
10.5 Inorganic Developments
10.5.1 Overview
11. Drug Delivery Systems Market–Key Company Profiles
11.1 3M
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 BD
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Boston Scientific Corporation
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Novo Nordisk A/S
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bausch Health Companies Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Baxter International, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Boehringer Ingelheim International Gmbh
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Novartis AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Glaxosmithkline Plc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Terumo Corporation
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product portfolio
11.10.5 SWOT ANALYSIS
11.10.6 Key Developments
11.11 Johnson & Johnson Services, Inc.
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial Overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
Table 1. R&D Investments By Major Pharmaceutical Companies In Europe
Table 2. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 3. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 4. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 5. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 6. Europe Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 7. Europe Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 8. Europe Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 9. Europe Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 10. Europe Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 11. Europe Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 12. Europe Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 13. Europe Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 14. Europe Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 15. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 16. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 17. Germany Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 18. Germany Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 19. Germany Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 20. Germany Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 21. Germany Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 22. Germany Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 23. Germany Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 24. Germany Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 25. Germany Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 26. Germany Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 27. Germany Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 28. Germany Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 29. France Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route of Administration (US$ Mn)
Table 30. France Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 31. France Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 32. France Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 33. France Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 34. France Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 35. France Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 36. France Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 37. France Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 38. France Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 39. France Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 40. France Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 41. UK Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 42. UK Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 43. UK Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 44. UK Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 45. UK Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 46. UK Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 47. UK Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 48. UK Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 49. UK Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 50. UK Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 51. UK Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 52. UK Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 53. Organic Developments Done By Companies
Table 54. Inorganic Developments Done By Companies
Table 55. Glossary Of Terms, Drug Delivery Systems Market
LIST OF FIGURES
Figure 1. Germany Drug Delivery Systems Market, Revenue (US$ Mn), By Country 2018 & 2027
Figure 2. Europe Drug Delivery Systems Market By Route Of Administration, Market Share (%), 2018
Figure 3. Europe Drug Delivery Systems Market By Application, Market Share (%), 2018
Figure 4. Europe Drug Delivery Systems Market By Distribution Channel, Market Share (%), 2018
Figure 5. Drug Delivery Systems Market Segmentation
Figure 6. Europe PEST Analysis
Figure 7. Drug Delivery Systems Market Impact Analysis Of Drivers & Restraints
Figure 8. Europe Drug Delivery Systems Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 9. Europe Drug Delivery Systems Market, By Route Of Administration, 2018 & 2027 (%)
Figure 10. Oral Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 11. Solid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. Liquid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 13. Semi-Solid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 14. Transmucosal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 15. Pulmonary Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 16. In-Metered Dose Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 17. Dry Powder Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 18. Nebulizers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Nasal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. Nasal Spray Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 21. Nasal Spray Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. Nasal Gel Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 23. Buccal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. Sublingual Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 25. Rectal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Vaginal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Topical Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Semi-Solid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. Liquid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 30. Solid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 31. Transdermal Patches Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 32. Transdermal Gels Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 33. Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 34. Injectable Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 35. Conventional Injection Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 36. Self-Injection Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 37. Needle Free Injectors Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 38. Pen Injectors Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 39. Wearable Injectors Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 40. Implantable Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 41. Active Implantable Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 42. Passive Implantable Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 43. Ocular Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 44. Eye Drops And Spray Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 45. Gels & Ointments Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 46. Ocular Inserts Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 47. Drug Coated Contact Lens Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 48. Europe Drug Delivery Systems Market By Application, 2017 & 2025 (%)
Figure 49. Europe Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 50. Europe Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 51. Europe Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 52. Europe Drug Delivery Systems Market By Distribution Channel, 2018 & 2027 (%)
Figure 53. Europe Hospital Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 54. Europe Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 55. Europe Online Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 56. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 57. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Country (%)
Figure 58. Germany Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 59. France Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 60. UK Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 61. Comparative Company Analysis
Figure 62. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies
- BD
- Novo Nordisk A/S
- 3M
- Boston Scientific Corporation
- Bausch Health Companies Inc.
- Baxter International, Inc.
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.